The researchers from Melbourne’s La Trobe University in cooperation with the biotechnology company AdAlta developed a drug, AD-114, that can help treat idiopathic pulmonary fibrosis (IPF). This condition affects the lung tissues and it results in progressively harder breathing.
The scientists hope that this drug, inspired by an antibody found in the sharks’ blood can treat the condition successfully. They can start human trials already within the next year.
Dr Mick Foley, one of the researchers from the La Trobe Institute for Molecular Science, says: “Fibrosis is the end result of a lot of different insults and injuries. This molecule can kill the cells that cause fibrosis.”